A Sydney doctor, who wishes to remain anonymous, has sent in the following piece examining the complexities of conflict of interest issues. It’s timely in view of the approaching NHMRC workshop on this issue, and recent debate surrounding Vioxx promotions, industry sponsored guidelines for DVT prevention, and the Baker/Sanofi deal, amongst other things.
The doctor writes:
It’s [...]
-
Pages
-
Categories
- adverse events
- alcohol
- Australian Medical Association
- cancer
- child health
- childbirth and maternity services
- chronic diseases
- climate change
- Cochrane Collaboration
- complementary medicines
- conflicts of interest
- consumer health information
- Crikey register of influence
- Croakey Register of Unreleased Documents
- dental care
- e-health
- education
- environmental health
- evidence-based issues
- Federal Budget 2009-2010
- Food
- general practice
- global health
- health & medical marketing
- health and medical education
- health and medical research
- health ethics
- health financing and costs
- Health inequalities
- health reform
- health regulation
- health workforce
- Hospitals
- HRT
- illicit drugs
- Indigenous education
- Indigenous health
- infectious diseases
- influenza
- international medical graduates
- Journal articles
- legal issues
- Media-related issues
- medical education
- men's health
- mental health
- NHMRC
- NT Intervention
- nurses and nursing
- obesity
- pathology
- pharmaceutical industry
- pharmacy
- physical activity
- poverty
- prevention
- primary health care
- private health insurance
- public health
- quality and safety of health care
- rural and remote health
- screening
- surgery
- swine flu
- tests
- TGA
- tobacco control
- trauma
- Uncategorized
- weight loss products
-
Archives
